SANTA CLARA, Calif. & AUSTIN, Texas--(BUSINESS WIRE)--Affymetrix Inc. (NASDAQ: AFFX) and Luminex Corporation (NASDAQ: LMNX) today announced a distribution agreement under which eBioscience, a business ...

HOUSTON & SANTA CLARA, Calif.--(BUSINESS WIRE)--Family Tree DNA, the first and largest genealogical DNA testing company, today announced the launch of the Family Finder DNA test for connecting family ...

Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...

Genomatix Software GmbH today announced that it has achieved GeneChip-compatible TM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has ...

Affymetrix said today it will collaborate with XRGenomics to develop next-generation diagnostic tests for age-related diseases. The alliance builds on an existing partnership between the companies, as ...

Unique and optimized solution provides highly sensitive and reproducible RNA amplification and labeling from archived FFPE samples for biomarker discovery and validation on industry-leading ...

Affymetrix ($AFFX) has sealed a deal with Leica Microsystems to automate a lab test intended, in part, to help boost development of new companion diagnostic tests ...

A multicenter comparison of equipment that can analyze the expression of thousands of genes at once to create a genetic "fingerprint," suggests these different microarray technologies are more alike ...

Thermo Fisher Scientific has reached a deal to buy genetic analysis expert Affymetrix for $1.3 billion. The $14.00-per-share purchase price is about 50% above Affymetrix’s share price after the stock ...

Mindy Lee-Olsen, 408-731-5523 (Media)Vice President, Marketing ServicesorDoug Farrell, 408-731-5285 (Investors)Vice President, Investor Relations (NASDAQ:AFFX) announced today the availability of ...